Research
Hormonal
Endogenous natural peptides have attracted increasing attention for fighting obesity.
Practitioners should consider the potential of endogenous peptides in obesity management.
StrongSupportsmedium confidence
Additionally, endogenous natural peptides have attracted increasing attention for fighting obesity recently.
Why this rating
The claim is based on a review of recent findings.
Source
A review: Anti-obesity drug discovery from natural plant metabolites and endogenous peptides
Xiaomu Zhu et al. · Current Research in Biotechnology · 2024
DOI 10.1016/j.crbiot.2024.100259
reviewCited 4×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →